S. Korean health authorities reject baseless 'Omicron surge' warning
As South Korea battled a spike in flu cases, misinformation swirled online that the country was suffering a resurgence of the ...
生物通29 天
华西医院团队研发XBB三价广谱新冠疫苗取得突破性进展
这款疫苗已于2023年6月获得国家紧急使用批准，是全球首款针对XBB毒株的重组蛋白疫苗。 新冠病毒的快速变异使得疫苗研发面临持续挑战。随着新亚型的出现，现有疫苗常常难以快速适应病毒的变化，迫切需要开发能够对抗多种变异株的广谱疫苗。虽然XBB.1.5亚 ...
VERIFY on MSN5 个月
No, the CDC hasn’t issued a ‘health advisory’ about the XBB COVID-19 subvariant
Editor’s note: Posts that falsely claim the CDC has issued a health advisory about the XBB subvariant of COVID-19 are circulating again on Facebook in August 2024. The same false message has ...
Forbes1 年
FDA Approves A New Covid-19 Booster, Targeting XBB.1.5
The prevalence of this subvariant quickly increased, prompting the development of the latest Covid-19 vaccine formulations. But XBB.1.5 no longer is the dominant variant. In May 2023, XBB.1.5 ...
SBS1 年
今年迄今逾80万澳人确诊 最新新冠疫苗将于12月中旬提供
Source: AAP / Albert Perez 要点 联邦政府已经批准了针对Omicron亚变种病毒的单价疫苗； 研究发现，新的XBB.1.5疫苗能适度提高对目前流行毒株的保护能力 ...
TASS1 年
Coronavirus variant XBB.1.5 to dominate in Europe in near future — EMA
THE HAGUE, February 15. /TASS/. The coronavirus subvariant XBB.1.5 will become dominant in the EU in the coming weeks, Head of Health Threats and Vaccines Strategy at the European Medicines Agency ...
scmp.com1 年
First batch of vaccines targeting Covid-19’s XBB variant will be in Hong Kong by year-end
The first batch of Covid-19 vaccines that target the XBB variant will arrive in Hong Kong by the end of the year, SCMP has learned. Secretary for Health Lo Chung-mau on Thursday said the ...